Editorial
Pneumonectomy—a necessary evil?
Translational Lung Cancer Research
2025;
14
(5)
:1496-1499
.
(30 May 2025)
Expert Consensus
Chinese expert consensus on shape-sensing robotic-assisted bronchoscopy (ssRAB) in the management of peripheral pulmonary lesions
Translational Lung Cancer Research
2025;
14
(5)
:1500-1515
.
(30 May 2025)
Original Article
A Bayesian deep learning model with consolidation-to-tumor ratio (CTR) prior revolutionizes the prediction of spread through air spaces (STAS) in stage IA lung adenocarcinoma: a large-scale diagnostic study
Translational Lung Cancer Research
2025;
14
(5)
:1516-1530
.
(30 May 2025)
Clinicopathological factors vs. molecular model for predicting adjuvant EGFR-TKI benefit in stage I EGFR-mutant non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(5)
:1531-1542
.
(30 May 2025)
Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(5)
:1543-1557
.
(30 May 2025)
Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression
Translational Lung Cancer Research
2025;
14
(5)
:1558-1568
.
(30 May 2025)
Prognostic factors of liver metastases in extensive-stage small cell lung cancer receiving chemo-immunotherapy
Translational Lung Cancer Research
2025;
14
(5)
:1569-1581
.
(30 May 2025)
Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
Translational Lung Cancer Research
2025;
14
(5)
:1582-1595
.
(30 May 2025)
Attention mechanism-based habitat analysis for predicting pleural invasion and prognosis of pulmonary nodules
Translational Lung Cancer Research
2025;
14
(5)
:1596-1610
.
(30 May 2025)
Radial endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) enhances diagnostic yield in pulmonary nodule biopsy
Translational Lung Cancer Research
2025;
14
(5)
:1611-1621
.
(30 May 2025)
Ivonescimab plus chemotherapy in advanced or metastatic non‐squamous non‐small cell lung cancer with EGFR variant in China: a cost‐effectiveness analysis
Translational Lung Cancer Research
2025;
14
(5)
:1622-1634
.
(30 May 2025)
Pattern-based volumetric CT quantification to predict radiation pneumonitis in patients with non-small-cell lung cancer who have diffuse parenchymal lung disease
Translational Lung Cancer Research
2025;
14
(5)
:1635-1649
.
(30 May 2025)
Re-irradiation for local recurrence after definitive stereotactic body radiotherapy for early-stage non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(5)
:1650-1659
.
(30 May 2025)
Impaired natural killer cell maturation in lung adenocarcinoma driven by FABP4 and SPON2 downregulation through disrupted lipid metabolism
Translational Lung Cancer Research
2025;
14
(5)
:1660-1676
.
(30 May 2025)
Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study
Translational Lung Cancer Research
2025;
14
(5)
:1677-1687
.
(30 May 2025)
Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial
Translational Lung Cancer Research
2025;
14
(5)
:1688-1698
.
(30 May 2025)
Different prognosis of multiple lung cancer identified by 116-gene panel by next-generation sequencing based on an Asian population
Translational Lung Cancer Research
2025;
14
(5)
:1699-1714
.
(30 May 2025)
Oral microbiome and risk of lung cancer: results from a two-sample mendelian randomization analysis
Translational Lung Cancer Research
2025;
14
(5)
:1715-1723
.
(30 May 2025)
Combination of immune checkpoint inhibitors with multi-targeted tyrosine kinase inhibitors for second- or later-line therapy of non-small cell lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2025;
14
(5)
:1724-1739
.
(30 May 2025)
Construction of a checkpoint inhibitor-related pneumonia diagnostic model based on exhaled nitric oxide: a prospective observational study
Translational Lung Cancer Research
2025;
14
(5)
:1740-1755
.
(30 May 2025)
Deep learning in histopathology images for prediction of oncogenic driver molecular alterations in lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2025;
14
(5)
:1756-1769
.
(30 May 2025)
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis
Translational Lung Cancer Research
2025;
14
(5)
:1770-1785
.
(30 May 2025)
One-year mortality risk prediction model for patients with interstitial lung disease and lung cancer
Translational Lung Cancer Research
2025;
14
(5)
:1786-1803
.
(30 May 2025)
Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations
Translational Lung Cancer Research
2025;
14
(5)
:1804-1820
.
(30 May 2025)
Review Article
Surgery without distance: will 5G-based robot-assisted telesurgery redefine modern surgery?
Translational Lung Cancer Research
2025;
14
(5)
:1821-1829
.
(30 May 2025)
Opportunities and challenges in lung cancer care in the era of large language models and vision language models
Translational Lung Cancer Research
2025;
14
(5)
:1830-1847
.
(30 May 2025)
Impacts of co-mutations in oligometastatic and oligoprogressive non-small cell lung cancer with EGFR/ALK mutations—a narrative review of the current literature
Translational Lung Cancer Research
2025;
14
(5)
:1848-1861
.
(30 May 2025)
Case Report
Visceral crisis in a patient with non-small cell lung cancer and ROS1::SDC4 fusion: intrinsic resistance to entrectinib via L2026M mutation—a case report
Translational Lung Cancer Research
2025;
14
(5)
:1862-1869
.
(30 May 2025)
Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with MET exon 14 skipping mutation: a case report and review of the literature
Translational Lung Cancer Research
2025;
14
(5)
:1870-1876
.
(30 May 2025)
Editorial Commentary
Emotional distress: the hidden barrier to immunotherapy success in advanced non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(5)
:1877-1881
.
(30 May 2025)
Perioperative immunochemotherapy in stage IIIA non-small cell lung cancer: insights on the path forward
Translational Lung Cancer Research
2025;
14
(5)
:1882-1886
.
(30 May 2025)
Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)—insights from the TROPiCS-03 trial
Translational Lung Cancer Research
2025;
14
(5)
:1887-1891
.
(30 May 2025)
